Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

German scientists from Tübingen and Mainz have developed a blood test that can reliably detect gene doping even after 56 days. Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping…

 

Lifeloc Technologies, Inc., a leading manufacturer of professional breathalyzers has released the industry’s first independent report on the accuracy and reliability of popular semiconductor (silicone oxide) breath testers sold in mass retail, pharmacy, specialty stores and on the Internet…

 

Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug and alcohol abuse, has announced the expansion of its oral fluid testing capabilities. The company is the first lab in the nation to develop an analytical test capable of detecting Ethyl Sulfate (EtS) in saliva, a chemical produced by the body after alcohol exposure…

 

Both legitimate brewers and distillers and authorities on the track of illicit alcohol from home stills will soon have a helping hand. Measurement experts have unveiled a portable device to determine the strength of alcoholic drinks quickly and easily, almost anywhere…

 

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has successfully carried out human clinical trials of its newest finger-touch detection system for alcohol intoxication, in collaboration with Lovelace Scientific Resources…

 

A company that makes personal electronic alcohol monitors that secure to the ankle like a bracelet, is urging courts in the US to make more use of the devices over the holiday season, when there is usually a peak in the rate of alcohol-related offences…

 

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today unveiled its first comprehensive Physicians’ Outreach Initiative, NIDAMED, which gives medical professionals tools and resources to screen their patients for tobacco, alcohol, illicit, and nonmedical prescription drug use. The NIDAMED resources include an online screening tool, a companion quick reference guide, and a comprehensive resource guide for clinicians.

 

A precise, new nanotechnology treatment for drug addiction may be on the horizon as the result of research conducted at the University at Buffalo. Scientists in UB’s Institute for Lasers, Photonics and Biophotonics and UB’s Department of Medicine have developed a stable nanoparticle that delivers short RNA molecules in the brain to “silence” or turn off a gene that plays a critical role in many kinds of drug addiction.

 

Concateno plc, Europe’s largest provider of drug and alcohol testing programmes, and Royal Philips Electronics (NYSE:PHG, AEX:PHI) have today announced an innovative handheld drugs-of-abuse detection device. Concateno-Philips pioneering system will make testing for drugs such as cocaine and heroin quicker, simpler and easier enabling immediate point-of-care drug test results, similar to current alcohol tests.

 

Ineffective disposal of unwanted or expired medications can lead to abuse, pollution or accidental ingestion, according to Wyoming Department of Health pharmacists. “Prescription drug abuse is a growing concern in Wyoming and across the country,” said State Pharmacist Roxanne Homar. “No one wants to make the problem worse, and responsible, prompt disposal of medications can help.




September 2010
Mon Tue Wed Thu Fri Sat Sun
« Aug    
 12345
6789101112
13141516171819
20212223242526
27282930